Population
Homozygous CASQ2(R33Q/R33Q) mouse model of catecholaminergic polymorphic ventricular tachycardia (CPVT)
Design
Preclinical
Authors
Loading...
Does not yet inform CPVT management; leaves open whether CASQ2-R33Q ultrastructural changes drive human arrhythmias.
The CASQ2(R33Q/R33Q) mouse model of CPVT reveals that the mutation leads to reduced CASQ2 content, decreased SR calcium, and ultrastructural abnormalities in the junctional SR.
Rizzi et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: